Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal
Dromigny, J.Albert.; Nabeth, P.; Juergens-Behr, A.; Perrier-Gros-Claude, J.David.
Journal of Antimicrobial ChemoTherapy 56(1): 236-239
2005
ISSN/ISBN: 0305-7453
PMID: 15890716
DOI: 10.1093/jac/dki158
Accession: 012521149
Objectives: To assess overall resistance rates and risk factors for resistance to ampicillin, co-amoxiclav, nalidixic acid, fluoroquinolones and trimethoprim/sulfamethoxazole in Escherichia coli strains isolated from outpatients with acute urinary tract infection in Dakar (Senegal).Patients and methods: From June 2001 to June 2003, a prospective study was performed among Senegalese outpatients consulting at the Institut Pasteur of Dakar for urine analysis.
PDF emailed within 0-6 h: $19.90
Related References
Ukah, U.V.; Glass, M.; Avery, B.; Daignault, D.; Mulvey, M.R.; Reid-Smith, R.J.; Parmley, E.J.; Portt, A.; Boerlin, P.; Manges, A.R. 2018: Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections Epidemiology and Infection 146(1): 46-57Sotto, A.; De Boever, C.M.; Fabbro-Peray, P.; Gouby, A.; Sirot, D.; Jourdan, J. 2001: Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study Journal of Clinical Microbiology 39(2): 438-444
Arslan, H.; Azap, O.K.; Ergönül, O.; Timurkaynak, F. 2005: Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey Journal of Antimicrobial ChemoTherapy 56(5): 914-918
Azap, O.K.; Arslan, H.; Serefhanoglu, K.; Colakoglu, S.; Erdogan, H.; Timurkaynak, F.; Senger, S.S. 2010: Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections Clinical Microbiology and Infection 16(2): 147-151
Azap, O.K.; Arslan, H.; Serefhanoğlu, K.; Colakoğlu, S.; Erdoğan, H.; Timurkaynak, F.; Senger, S.S. 2010: Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 16(2): 147-151
Kim, B.; Seo, M.R.; Kim, J.; Kim, Y.; Wie, S.H.; Ki, M.; Cho, Y.K.; Lim, S.; Lee, J.S.; Kwon, K.T.; Lee, H.; Cheong, H.J.; Park, D.W.; Ryu, S.Y.; Chung, M.H.; Pai, H. 2020: Molecular Epidemiology of Ciprofloxacin-Resistant Escherichia coli Isolated from Community-Acquired Urinary Tract Infections in Korea Infection and ChemoTherapy 52(2): 194-203
Haitham, A.S.N.; Cristea, V.C.; Gheorghe, I.; Irrayif, S.M.; Mohammed, H.B.; Sadik, O.; Mihaescu, G. 2021: Antibiotic resistance features in Klebsiella pneumoniae and Escherichia coli strains isolated from hospital and community acquired urinary tract infections Romanian Biotechnological Letters 26(1): 2244-2248
Killgore, K.M.; March, K.L.; Guglielmo, B.J. 2004: Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection Annals of PharmacoTherapy 38(7-8): 1148-1152
Marcus, N.; Ashkenazi, S.; Yaari, A.; Samra, Z.; Livni, G. 2005: Non-Escherichia coli versus Escherichia coli community-acquired urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and outcome Pediatric Infectious Disease Journal 24(7): 581-585
Guzmán, M.; Salazar, E.; Cordero, V.; Castro, A.; Villanueva, Aína.; Rodulfo, H.; De Donato, M. 2019: Multidrug resistance and risk factors associated with community-acquired urinary tract infections caused by Escherichia coli in Venezuela Biomedica: revista del Instituto Nacional de Salud 39(s1): 96-107
Mulder, M.; Kiefte-de Jong, J.C.; Goessens, W.H.F.; de Visser, H.; Hofman, A.; Stricker, B.H.; Verbon, A. 2017: Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population Journal of Antimicrobial ChemoTherapy 72(1): 281-289
Paniagua-Contreras, G.L.; Monroy-Pérez, E.; Rodríguez-Moctezuma, J.é R.; Domínguez-Trejo, P.; Vaca-Paniagua, F.; Vaca, S. 2017: Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico Journal of Microbiology Immunology and Infection 50(4): 478-485
Guajardo-Lara, C.E.; González-Martínez, P.M.; Ayala-Gaytán, J.J. 2009: Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections. what antimicrobial to use? Salud Publica de Mexico 51(2): 155-159
Larramendy, S.ép.; Deglaire, V.; Dusollier, P.; Fournier, J.-P.; Caillon, J.; Beaudeau, F.ço.; Moret, L.ïl. 2020: Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: a Systematic Review Infection and Drug Resistance 13: 3945-3955
Butcher, C.R.; Rubin, J.; Mussio, K.; Riley, L.W. 2019: Risk Factors Associated with Community-Acquired Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli: a Systematic Review Current Epidemiology Reports 6(3): 300-309
Syre, H.; Hetland, M.A.K.; Bernhoff, E.; Bollestad, M.; Grude, N.; Simonsen, G.S.; Löhr, I.H.øy. 2020: Microbial risk factors for treatment failure of pivmecillinam in community-acquired urinary tract infections caused by ESBL-producing Escherichia coli Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 128(3): 232-241
Yilmaz, E.; Akalin, H.; Ozbey, S.; Kordan, Y.; Sinirtaş, M.; Gürcüoglu, E.; Ozakin, C.; Heper, Y.; Mistik, R.; Helvaci, S. 2008: Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae Journal of ChemoTherapy 20(5): 581-585
Koksal, E.; Tulek, N.; Sonmezer, M.C.; Temocin, F.; Bulut, C.; Hatipoglu, C.; Erdinc, F.S.; Ertem, G. 2019: Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species Investigative and Clinical Urology 60(1): 46-53
Radera, S.; Srivastava, S.; Agarwal, J. 2022: Virulence Genotyping and Multidrug Resistance Pattern of Escherichia coli Isolated from Community-Acquired and Hospital-Acquired Urinary Tract Infections Cureus 14(9): E29404
Sümer, Z.; Coskunkan, F.; Vahaboglu, H.; Bakir, M. 2005: The resistance of Escherichia coli strains isolated from community-acquired urinary tract infections Advances in Therapy 22(5): 419-423